Dietary Interventions for Osteoarthritis Pain
(DIRECTPain Trial)
Trial Summary
What is the purpose of this trial?
Knee osteoarthritis (OA) is the most prevalent form of arthritis and race is a risk factor for poor outcomes. Non-Hispanic Black individuals (NHB) report greater disability and pain severity compared to Non-Hispanic Whites (NHW). These differences are reinforced through social and biological mechanisms, ultimately resulting in disparities in pain experience and associated quality of life. National efforts to reduce analgesic utilization highlight the critical need for safe, effective, and accessible alternatives for pain relief for underserved/at-risk populations. Low-carbohydrate diets (LCDs) reduce inflammation and pain independent of weight loss, indicating that diet interventions offer a non-pharmacological alternative. However, racial differences exist in metabolism that are rarely addressed in diet intervention studies. Therefore, a LCD may have greater pain-reducing effects in NHBs and provide an alternative treatment for pain. This will be the first study to examine the efficacy of these diets to reduce knee OA pain with an emphasis on race and interactions with biopsychosocial variables. Aim 1: To investigate the efficacy of the LCD to reduce pain and improve QOL. Hypothesis 1: The LCD group will show significantly greater reductions in: self-reported pain and evoked pain when compared to the USDA diet. Hypothesis 2: The LCD group will show greater improvements in: QOL, mood, and self-reported improvement. Hypothesis 3: Both diets will result in improved pain disability, severity, catastrophizing and pain-related fear; the LCD will outperform the USDA diet. Objective 2: To explore racial differences in diet effects and baseline measures. Hypothesis 1: NHBs will show greater improvements in pain, QOL, and mood. Hypothesis 2: NHBs will report greater food insecurity and less proximity to grocery stores. Hypothesis 3: Diet quality will be negatively associated with baseline pain sensitivity. Objective 3: To determine whether physiological variables contribute to diet effects or lack thereof. Hypothesis 1: Baseline physiological measures will predict: pain sensitivity and reductions in pain. NHBs will show greater inflammation at baseline than NHWs. Hypothesis 2: Change in physiological measures will be related to: change in pain, change in QOL, self-reported improvement and mood. NHWs will show greater reductions in inflammation and adiposity than NHBs.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use daily opioid pain medications or medications that alter metabolism or digestion.
What data supports the effectiveness of the low-carbohydrate diet treatment for osteoarthritis pain?
Research shows that low-carbohydrate diets can help with weight loss and improve heart health, which might indirectly benefit osteoarthritis by reducing stress on joints and improving overall health. Many people have successfully used these diets to lose weight and maintain it, which could help alleviate joint pain associated with osteoarthritis.12345
Is the Atkins diet safe for humans?
How does the low-carbohydrate diet treatment for osteoarthritis differ from other treatments?
The low-carbohydrate diet treatment for osteoarthritis is unique because it focuses on reducing carbohydrate intake, which may help manage weight and inflammation, both of which are linked to osteoarthritis symptoms. Unlike other treatments that may focus on medication or physical therapy, this dietary approach targets the potential role of diet in reducing pain and improving joint function.1011121314
Research Team
Robert E Sorge, PhD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for English-speaking adults aged 40-75 with knee osteoarthritis, who self-identify as either Non-Hispanic Black or White, have a BMI of 25-40, eat more than 100g of carbs daily, and experience pain most days. Excluded are those on opioids or certain other meds, with recent weight change, major surgery like knee replacement, severe diseases affecting heart/lungs/digestion/metabolism, extreme exercisers or dieters.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including anthropometric measures, actigraphy, and diet-related questionnaires
Diet Intervention
Participants are randomly assigned to either a Low-Carbohydrate Diet (LCD) or USDA diet, with weekly food delivery and monitoring
Follow-up
Participants are monitored for changes in pain, quality of life, and physiological measures after the intervention
Treatment Details
Interventions
- Low-carbohydrate diet
- USDA Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor